<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05057299</url>
  </required_header>
  <id_info>
    <org_study_id>20 KHCC 169</org_study_id>
    <nct_id>NCT05057299</nct_id>
  </id_info>
  <brief_title>Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes</brief_title>
  <official_title>Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Hussein Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Hussein Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with extramedullary leukemia were identified over 10 years (January 2003 to&#xD;
      September 2019). Clinicopathological,genetic-molecular features were identified and survival&#xD;
      outcomes were studied and analyzed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We retrospectively collected patients demographics ,including clinicopathological and&#xD;
      genetic-molecular parameters in patients with extramedullary leukemia between January 2003&#xD;
      till September 2019 from King Hussein cancer center(KHCC) electronic medical records. All&#xD;
      potential prognostic factors were identified and compared with worldwide data published&#xD;
      previously. Treatment and survival outcomes were studies and analyzed.&#xD;
&#xD;
      Primary endpoint : Overall survival (OS).&#xD;
&#xD;
      Secondary endpoint :&#xD;
&#xD;
        -  Progression Free Survival (PFS).&#xD;
&#xD;
        -  incidence of extramedullary leukemia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Actual">January 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival (OS),</measure>
    <time_frame>&quot;4 year, year 4&quot;</time_frame>
    <description>To calculate the median and estimated 4-year overall survival</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression-Free Survival</measure>
    <time_frame>&quot;4 year, year 4&quot;</time_frame>
    <description>To calculate the median and estimated 4-year PFS</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">32</enrollment>
  <condition>Acute Myeloid Leukemia</condition>
  <arm_group>
    <arm_group_label>Patients with extramedullary leukemia(eAML) with myeloid neoplasms</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>retrospective data analysis</intervention_name>
    <description>chart review, analysis and reporting outcomes</description>
    <arm_group_label>Patients with extramedullary leukemia(eAML) with myeloid neoplasms</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with eAML and treated at medical oncology department of KHCC-lymphoma&#xD;
        section between January 2003-september 2019.Patients identified by searching KHCC registry&#xD;
        databases, using key terms of myeloid sarcoma, granulocytic sarcoma, chloroma, AML, MDS,&#xD;
        MPN, relapse. All clinicopathological and molecular data were collected and cases, that&#xD;
        satisfied the WHO criteria for the diagnosis of myeloid sarcoma were included in the study.&#xD;
        The clinicopathological data included age, sex, prior diagnoses and treatment, disease&#xD;
        location, phenotype using flow cytometry or immunohistochemistry, status of bone marrow&#xD;
        disease (prior, concurrent or after diagnosis of eAMl), treatment for eAML and their&#xD;
        overall survival.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult subjects aged â‰¥18 year and up to 75 years&#xD;
&#xD;
          -  Male and females.&#xD;
&#xD;
          -  Initially diagnosed and treated with extramedullary leukemia at KHCC and followed till&#xD;
             last encounter.&#xD;
&#xD;
          -  Patients, who underwent an allogeneic stem cell transplant.&#xD;
&#xD;
          -  Period January 2003-September 2019&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pediatric patients &lt;18 year of age&#xD;
&#xD;
          -  Patients, who lost their follow up within study period.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>males and females</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>King Hussein Cancer Center</name>
      <address>
        <city>Amman</city>
        <zip>11941</zip>
        <country>Jordan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Jordan</country>
  </location_countries>
  <reference>
    <citation>Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood Rev. 2019 Jul;36:70-87. doi: 10.1016/j.blre.2019.04.005. Epub 2019 Apr 29. Review.</citation>
    <PMID>31101526</PMID>
  </reference>
  <results_reference>
    <citation>Shallis RM, Gale RP, Lazarus HM, Roberts KB, Xu ML, Seropian SE, Gore SD, Podoltsev NA. Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved. Blood Rev. 2021 May;47:100773. doi: 10.1016/j.blre.2020.100773. Epub 2020 Oct 30. Review.</citation>
    <PMID>33213985</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 2, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Hussein Cancer Center</investigator_affiliation>
    <investigator_full_name>Khaled Halahleh</investigator_full_name>
    <investigator_title>Consultant, Medical Oncologist-BMT consultant</investigator_title>
  </responsible_party>
  <keyword>AML</keyword>
  <keyword>leukemia,</keyword>
  <keyword>myeloid sarcoma</keyword>
  <keyword>extramedullary disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Leukemia, Myeloid</mesh_term>
    <mesh_term>Leukemia, Myeloid, Acute</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

